[Federal Register Volume 66, Number 219 (Tuesday, November 13, 2001)]
[Notices]
[Page 56828]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-28434]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee on Immunization Practices: Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following committee meeting:

    Name: Advisory Committee on Immunization Practices (ACIP) 
Teleconference.
    Time and Date: 12 p.m.-3 p.m., November 8, 2001.
    Place: Teleconference call will originate at the Centers for 
Disease Control and Prevention in Atlanta, Georgia.
    Status: Closed.
    Purpose: The Committee is charged with advising the Director, 
CDC, on the appropriate uses of immunizing agents. In addition, 
under 42 U.S.C. 1396s, the Committee is mandated to establish and 
periodically review and, as appropriate, revise the list of vaccines 
for administration to vaccine-eligible children through the Vaccines 
for Children (VFC) program, along with schedules regarding the 
appropriate periodicity, dosage, and contraindications applicable to 
the vaccines.
    Matters to be Discussed: The teleconference will convene in 
closed session from 12:00 p.m. to 3:00 p.m. on November 8, 2001. The 
purpose of this closed session is to discuss human exposure to B. 
anthracis spores in humans in the United States. This teleconference 
will be closed to the public in accordance with provisions set forth 
in 5 U.S.C. subsections 552b (c)(1), (c)(7) and (c)(9)(B), and the 
Determination of the Associate Director for Management and 
Operations, CDC, pursuant to subsection 10(d) of Pub. L. 92-463.
    Supplementary information: This conference call is scheduled for 
12 p.m. Eastern Standard Time. As provided under 5 U.S.C. 552b(e) 
and 41 CFR section 102-3.150(b), the public health urgency of this 
agency business requires that the meeting be held on or prior to the 
first available date for publication of this notice in the Federal 
Register.
    Due to programmatic issues that had to be resolved, the Federal 
Register notice is being published less than fifteen days before the 
date of the meeting.
    Contact Person for More Information: Gloria A. Kovach, Program 
Analyst, Epidemiology and Surveillance Division, National 
Immunization Program, CDC, 1600 Clifton Road, NE, m/s E61, Atlanta, 
Georgia 30333. Telephone 404/639-8096.
    The Director, Management Analysis and Services office has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.

    Dated: November 7, 2001.
John Burckhardt,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 01-28434 Filed 11-8-01; 11:55 am]
BILLING CODE 4163-18-P